Clinical Trial Update: Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC [Phase 2]

View source ↗

Summary

Phase 2 trial comparing goserelin plus letrozole in premenopausal patients versus letrozole alone in postmenopausal patients with metastatic breast cancer; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)
• Zoladex (goserelin)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED